FAMI
REGN icon

Fideuram Asset Management (Ireland)’s Regeneron Pharmaceuticals REGN Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
6,329
+5,857
+1,241% +$3.99M 0.07% 360
2026
Q1 		$365K Sell
472
-12,639
-96% -$9.68M 0.05% 273
2025
Q4 		$8.86M Buy
+13,111
New +$8.9M 0.7% 30

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s REGN Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) increased its Regeneron Pharmaceuticals (REGN) stake by 1,241% in Q2 2026, buying an estimated $3.99M and bringing the position to 6,329 shares worth $3.92M. The position accounts for 0.07% of the portfolio, ranked #360.

Fideuram Asset Management (Ireland) first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.86M in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 6,329 shares of Regeneron Pharmaceuticals worth $3.92M as of Q2 2026.
  • Fideuram Asset Management (Ireland) bought 5,857 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.99M.
  • Regeneron Pharmaceuticals made up 0.07% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #360 holding.
  • Fideuram Asset Management (Ireland) first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Fideuram Asset Management (Ireland)'s Regeneron Pharmaceuticals position peaked at $8.86M in Q4 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.